A clinical trial to study the effects of two drugs, nagaradi eye drops and vachaharidradi application in patients with allergic conjuctivitis

A comparative study of nagaradi aschyotana and vachaharidradi vidalaka in the management of kaphaja abhishyanda (simple allergic conjuctivitis) - NAVV

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/04/024696

Enrollment

Registered

2020-04-16

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H108- Other conjunctivitis

Interventions

Intervention1: Nagaradi Aschyotana: 8 drops of medicine should be instilled to the eye twice daily for 7 days Control Intervention1: Vachaharidradi Vidalaka: Quantity sufficient medicine should be app

Eligibility

Inclusion criteria

Inclusion criteria: Patients above 5 years Patients presenting with clinical features of Kaphaja Abhishyanda(Simple allergic conjunctivitis) will be selected

Exclusion criteria

Exclusion criteria: Patients having other types of Conjuctivitis, Marginal corneal ulcer, Dacryocystitis and other ocular manifestations Patients suffering with systemic disorders Patients having genetic predisposition to allergy

Design outcomes

Primary

Measure	Time frame
1.Watering of eye 2.Itching 3.Burning sensation 4.Congestion of bulbar and palpebral conjuctiva 5.Chemosis 6.Papillary reaction 7.Foreign body sensation Timepoint: 21 days	—

Secondary

Measure	Time frame
Not applicableTimepoint: Not applicable	—

Countries

India

Contacts

Public ContactDr Pradeep Kumar K

Alvas Ayurveda Medical College and Hospital

drpradeepkayu@gmail.com9986576898

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026